Global Recombinant Peptides Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

January 2022 | 118 pages | ID: G0CABE6EB608EN
Maia Research

Abstracts

Based on the Recombinant Peptides market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Recombinant Peptides market covered in Chapter 5:
Actavis
Cipla Ltd.
Stada Arzneimittel
Hospira
Amgen
Sandoz Pharma
Wockhardt Ltd.
Biocon Ltd.

In Chapter 6, on the basis of types, the Recombinant Peptides market from 2015 to 2025 is primarily split into:
Glucagon
Calcitonin
Other

In Chapter 7, on the basis of applications, the Recombinant Peptides market from 2015 to 2025 covers:
Insulin
Human Growth Hormone
Blood Products
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 MARKET OVERVIEW

1.1 Product Definition and Market Characteristics
1.2 Global Recombinant Peptides Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. MARKET DYNAMICS

2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
  2.4.1 Short-term Impact
  2.4.2 Long-term Impact

3 ASSOCIATED INDUSTRY ASSESSMENT

3.1 Supply Chain Analysis
3.2 Industry Active Participants
  3.2.1 Suppliers of Raw Materials
  3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 MARKET COMPETITIVE LANDSCAPE

4.1 Industry Leading Players
4.2 Industry News
  4.2.1 Key Product Launch News
  4.2.2 M&A and Expansion Plans

5 ANALYSIS OF LEADING COMPANIES

5.1 Actavis
  5.1.1 Actavis Company Profile
  5.1.2 Actavis Business Overview
  5.1.3 Actavis Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.1.4 Actavis Recombinant Peptides Products Introduction
5.2 Cipla Ltd.
  5.2.1 Cipla Ltd. Company Profile
  5.2.2 Cipla Ltd. Business Overview
  5.2.3 Cipla Ltd. Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.2.4 Cipla Ltd. Recombinant Peptides Products Introduction
5.3 Stada Arzneimittel
  5.3.1 Stada Arzneimittel Company Profile
  5.3.2 Stada Arzneimittel Business Overview
  5.3.3 Stada Arzneimittel Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.3.4 Stada Arzneimittel Recombinant Peptides Products Introduction
5.4 Hospira
  5.4.1 Hospira Company Profile
  5.4.2 Hospira Business Overview
  5.4.3 Hospira Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.4.4 Hospira Recombinant Peptides Products Introduction
5.5 Amgen
  5.5.1 Amgen Company Profile
  5.5.2 Amgen Business Overview
  5.5.3 Amgen Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.5.4 Amgen Recombinant Peptides Products Introduction
5.6 Sandoz Pharma
  5.6.1 Sandoz Pharma Company Profile
  5.6.2 Sandoz Pharma Business Overview
  5.6.3 Sandoz Pharma Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.6.4 Sandoz Pharma Recombinant Peptides Products Introduction
5.7 Wockhardt Ltd.
  5.7.1 Wockhardt Ltd. Company Profile
  5.7.2 Wockhardt Ltd. Business Overview
  5.7.3 Wockhardt Ltd. Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.7.4 Wockhardt Ltd. Recombinant Peptides Products Introduction
5.8 Biocon Ltd.
  5.8.1 Biocon Ltd. Company Profile
  5.8.2 Biocon Ltd. Business Overview
  5.8.3 Biocon Ltd. Recombinant Peptides Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  5.8.4 Biocon Ltd. Recombinant Peptides Products Introduction

6 MARKET ANALYSIS AND FORECAST, BY PRODUCT TYPES

6.1 Global Recombinant Peptides Sales, Revenue and Market Share by Types (2015-2020)
  6.1.1 Global Recombinant Peptides Sales and Market Share by Types (2015-2020)
  6.1.2 Global Recombinant Peptides Revenue and Market Share by Types (2015-2020)
  6.1.3 Global Recombinant Peptides Price by Types (2015-2020)
6.2 Global Recombinant Peptides Market Forecast by Types (2020-2025)
  6.2.1 Global Recombinant Peptides Market Forecast Sales and Market Share by Types (2020-2025)
  6.2.2 Global Recombinant Peptides Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Recombinant Peptides Sales, Price and Growth Rate by Types (2015-2020)
  6.3.1 Global Recombinant Peptides Sales, Price and Growth Rate of Glucagon
  6.3.2 Global Recombinant Peptides Sales, Price and Growth Rate of Calcitonin
  6.3.3 Global Recombinant Peptides Sales, Price and Growth Rate of Other
6.4 Global Recombinant Peptides Market Revenue and Sales Forecast, by Types (2020-2025)
  6.4.1 Glucagon Market Revenue and Sales Forecast (2020-2025)
  6.4.2 Calcitonin Market Revenue and Sales Forecast (2020-2025)
  6.4.3 Other Market Revenue and Sales Forecast (2020-2025)

7 MARKET ANALYSIS AND FORECAST, BY APPLICATIONS

7.1 Global Recombinant Peptides Sales, Revenue and Market Share by Applications (2015-2020)
  7.1.1 Global Recombinant Peptides Sales and Market Share by Applications (2015-2020)
  7.1.2 Global Recombinant Peptides Revenue and Market Share by Applications (2015-2020)
7.2 Global Recombinant Peptides Market Forecast by Applications (2020-2025)
  7.2.1 Global Recombinant Peptides Market Forecast Sales and Market Share by Applications (2020-2025)
  7.2.2 Global Recombinant Peptides Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  7.3.1 Global Recombinant Peptides Revenue, Sales and Growth Rate of Insulin (2015-2020)
  7.3.2 Global Recombinant Peptides Revenue, Sales and Growth Rate of Human Growth Hormone (2015-2020)
  7.3.3 Global Recombinant Peptides Revenue, Sales and Growth Rate of Blood Products (2015-2020)
  7.3.4 Global Recombinant Peptides Revenue, Sales and Growth Rate of Other (2015-2020)
7.4 Global Recombinant Peptides Market Revenue and Sales Forecast, by Applications (2020-2025)
  7.4.1 Insulin Market Revenue and Sales Forecast (2020-2025)
  7.4.2 Human Growth Hormone Market Revenue and Sales Forecast (2020-2025)
  7.4.3 Blood Products Market Revenue and Sales Forecast (2020-2025)
  7.4.4 Other Market Revenue and Sales Forecast (2020-2025)

8 MARKET ANALYSIS AND FORECAST, BY REGIONS

8.1 Global Recombinant Peptides Sales by Regions (2015-2020)
8.2 Global Recombinant Peptides Market Revenue by Regions (2015-2020)
8.3 Global Recombinant Peptides Market Forecast by Regions (2020-2025)

9 NORTH AMERICA RECOMBINANT PEPTIDES MARKET ANALYSIS

9.1 Market Overview and Prospect Analysis
9.2 North America Recombinant Peptides Market Sales and Growth Rate (2015-2020)
9.3 North America Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
9.4 North America Recombinant Peptides Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Recombinant Peptides Market Analysis by Country
  9.6.1 U.S. Recombinant Peptides Sales and Growth Rate
  9.6.2 Canada Recombinant Peptides Sales and Growth Rate
  9.6.3 Mexico Recombinant Peptides Sales and Growth Rate

10 EUROPE RECOMBINANT PEPTIDES MARKET ANALYSIS

10.1 Market Overview and Prospect Analysis
10.2 Europe Recombinant Peptides Market Sales and Growth Rate (2015-2020)
10.3 Europe Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
10.4 Europe Recombinant Peptides Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Recombinant Peptides Market Analysis by Country
  10.6.1 Germany Recombinant Peptides Sales and Growth Rate
  10.6.2 United Kingdom Recombinant Peptides Sales and Growth Rate
  10.6.3 France Recombinant Peptides Sales and Growth Rate
  10.6.4 Italy Recombinant Peptides Sales and Growth Rate
  10.6.5 Spain Recombinant Peptides Sales and Growth Rate
  10.6.6 Russia Recombinant Peptides Sales and Growth Rate

11 ASIA-PACIFIC RECOMBINANT PEPTIDES MARKET ANALYSIS

11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Recombinant Peptides Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Recombinant Peptides Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Recombinant Peptides Market Analysis by Country
  11.6.1 China Recombinant Peptides Sales and Growth Rate
  11.6.2 Japan Recombinant Peptides Sales and Growth Rate
  11.6.3 South Korea Recombinant Peptides Sales and Growth Rate
  11.6.4 Australia Recombinant Peptides Sales and Growth Rate
  11.6.5 India Recombinant Peptides Sales and Growth Rate

12 SOUTH AMERICA RECOMBINANT PEPTIDES MARKET ANALYSIS

12.1 Market Overview and Prospect Analysis
12.2 South America Recombinant Peptides Market Sales and Growth Rate (2015-2020)
12.3 South America Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
12.4 South America Recombinant Peptides Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Recombinant Peptides Market Analysis by Country
  12.6.1 Brazil Recombinant Peptides Sales and Growth Rate
  12.6.2 Argentina Recombinant Peptides Sales and Growth Rate
  12.6.3 Columbia Recombinant Peptides Sales and Growth Rate

13 MIDDLE EAST AND AFRICA RECOMBINANT PEPTIDES MARKET ANALYSIS

13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Recombinant Peptides Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Recombinant Peptides Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Recombinant Peptides Market Analysis by Country
  13.6.1 UAE Recombinant Peptides Sales and Growth Rate
  13.6.2 Egypt Recombinant Peptides Sales and Growth Rate
  13.6.3 South Africa Recombinant Peptides Sales and Growth Rate

14 CONCLUSIONS AND RECOMMENDATIONS

14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 APPENDIX

15.1 Methodology
15.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture
Figure Global Recombinant Peptides Market Size and Growth Rate 2015-2025
Table Recombinant Peptides Key Market Segments
Figure Global Recombinant Peptides Market Revenue ($) Segment by Type from 2015-2020
Figure Global Recombinant Peptides Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Recombinant Peptides
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Actavis Company Profile
Table Actavis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Actavis Production and Growth Rate
Figure Actavis Market Revenue ($) Market Share 2015-2020
Table Cipla Ltd. Company Profile
Table Cipla Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Cipla Ltd. Production and Growth Rate
Figure Cipla Ltd. Market Revenue ($) Market Share 2015-2020
Table Stada Arzneimittel Company Profile
Table Stada Arzneimittel Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Stada Arzneimittel Production and Growth Rate
Figure Stada Arzneimittel Market Revenue ($) Market Share 2015-2020
Table Hospira Company Profile
Table Hospira Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hospira Production and Growth Rate
Figure Hospira Market Revenue ($) Market Share 2015-2020
Table Amgen Company Profile
Table Amgen Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Amgen Production and Growth Rate
Figure Amgen Market Revenue ($) Market Share 2015-2020
Table Sandoz Pharma Company Profile
Table Sandoz Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Sandoz Pharma Production and Growth Rate
Figure Sandoz Pharma Market Revenue ($) Market Share 2015-2020
Table Wockhardt Ltd. Company Profile
Table Wockhardt Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Wockhardt Ltd. Production and Growth Rate
Figure Wockhardt Ltd. Market Revenue ($) Market Share 2015-2020
Table Biocon Ltd. Company Profile
Table Biocon Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Biocon Ltd. Production and Growth Rate
Figure Biocon Ltd. Market Revenue ($) Market Share 2015-2020
Table Global Recombinant Peptides Sales by Types (2015-2020)
Table Global Recombinant Peptides Sales Share by Types (2015-2020)
Table Global Recombinant Peptides Revenue ($) by Types (2015-2020)
Table Global Recombinant Peptides Revenue Share by Types (2015-2020)
Table Global Recombinant Peptides Price ($) by Types (2015-2020)
Table Global Recombinant Peptides Market Forecast Sales by Types (2020-2025)
Table Global Recombinant Peptides Market Forecast Sales Share by Types (2020-2025)
Table Global Recombinant Peptides Market Forecast Revenue ($) by Types (2020-2025)
Table Global Recombinant Peptides Market Forecast Revenue Share by Types (2020-2025)
Figure Global Glucagon Sales and Growth Rate (2015-2020)
Figure Global Glucagon Price (2015-2020)
Figure Global Calcitonin Sales and Growth Rate (2015-2020)
Figure Global Calcitonin Price (2015-2020)
Figure Global Other Sales and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Glucagon (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Glucagon (2020-2025)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Calcitonin (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Calcitonin (2020-2025)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Other (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Other (2020-2025)
Table Global Recombinant Peptides Sales by Applications (2015-2020)
Table Global Recombinant Peptides Sales Share by Applications (2015-2020)
Table Global Recombinant Peptides Revenue ($) by Applications (2015-2020)
Table Global Recombinant Peptides Revenue Share by Applications (2015-2020)
Table Global Recombinant Peptides Market Forecast Sales by Applications (2020-2025)
Table Global Recombinant Peptides Market Forecast Sales Share by Applications (2020-2025)
Table Global Recombinant Peptides Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Recombinant Peptides Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Insulin Sales and Growth Rate (2015-2020)
Figure Global Insulin Price (2015-2020)
Figure Global Human Growth Hormone Sales and Growth Rate (2015-2020)
Figure Global Human Growth Hormone Price (2015-2020)
Figure Global Blood Products Sales and Growth Rate (2015-2020)
Figure Global Blood Products Price (2015-2020)
Figure Global Other Sales and Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Insulin (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Insulin (2020-2025)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Human Growth Hormone (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Human Growth Hormone (2020-2025)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Blood Products (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Blood Products (2020-2025)
Figure Global Recombinant Peptides Market Revenue ($) and Growth Rate Forecast of Other (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate Forecast of Other (2020-2025)
Figure Global Recombinant Peptides Sales and Growth Rate (2015-2020)
Table Global Recombinant Peptides Sales by Regions (2015-2020)
Table Global Recombinant Peptides Sales Market Share by Regions (2015-2020)
Figure Global Recombinant Peptides Sales Market Share by Regions in 2019
Figure Global Recombinant Peptides Revenue and Growth Rate (2015-2020)
Table Global Recombinant Peptides Revenue by Regions (2015-2020)
Table Global Recombinant Peptides Revenue Market Share by Regions (2015-2020)
Figure Global Recombinant Peptides Revenue Market Share by Regions in 2019
Table Global Recombinant Peptides Market Forecast Sales by Regions (2020-2025)
Table Global Recombinant Peptides Market Forecast Sales Share by Regions (2020-2025)
Table Global Recombinant Peptides Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Recombinant Peptides Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure North America Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
Figure North America Recombinant Peptides Market Forecast Sales (2020-2025)
Figure North America Recombinant Peptides Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Canada Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Mexico Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Europe Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Europe Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
Figure Europe Recombinant Peptides Market Forecast Sales (2020-2025)
Figure Europe Recombinant Peptides Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure France Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Italy Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Spain Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Russia Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Recombinant Peptides Market Forecast Sales (2020-2025)
Figure Asia-Pacific Recombinant Peptides Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Japan Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure South Korea Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Australia Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure India Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure South America Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure South America Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
Figure South America Recombinant Peptides Market Forecast Sales (2020-2025)
Figure South America Recombinant Peptides Market Forecast Revenue ($) (2020-2025)
Figure Brazil Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Argentina Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Columbia Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Recombinant Peptides Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Recombinant Peptides Market Forecast Sales (2020-2025)
Figure Middle East and Africa Recombinant Peptides Market Forecast Revenue ($) (2020-2025)
Figure UAE Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure Egypt Recombinant Peptides Market Sales and Growth Rate (2015-2020)
Figure South Africa Recombinant Peptides Market Sales and Growth Rate (2015-2020)